Richard Rox Anderson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laser Therapy | 51 | 2010 | 1072 | 4.510 |
Why?
|
Aminolevulinic Acid | 10 | 2010 | 142 | 2.050 |
Why?
|
Lasers | 23 | 2007 | 952 | 2.000 |
Why?
|
Photochemotherapy | 17 | 2010 | 807 | 1.770 |
Why?
|
Tattooing | 8 | 2008 | 58 | 1.360 |
Why?
|
Skin | 40 | 2010 | 4364 | 1.290 |
Why?
|
Photosensitizing Agents | 10 | 2010 | 602 | 1.150 |
Why?
|
Lasers, Solid-State | 4 | 2009 | 169 | 1.150 |
Why?
|
Hair Removal | 8 | 2001 | 42 | 1.060 |
Why?
|
Hyperpigmentation | 5 | 2009 | 112 | 0.900 |
Why?
|
Microscopy, Confocal | 18 | 2006 | 1970 | 0.770 |
Why?
|
Port-Wine Stain | 3 | 2009 | 33 | 0.760 |
Why?
|
Acne Vulgaris | 3 | 2010 | 302 | 0.670 |
Why?
|
Skin Aging | 7 | 2004 | 127 | 0.630 |
Why?
|
Dermis | 5 | 2009 | 207 | 0.610 |
Why?
|
Dermatology | 4 | 2010 | 872 | 0.570 |
Why?
|
Microscopy, Polarization | 4 | 2005 | 88 | 0.540 |
Why?
|
Rhytidoplasty | 3 | 2002 | 60 | 0.520 |
Why?
|
Porphyrins | 4 | 2009 | 348 | 0.510 |
Why?
|
Skin Neoplasms | 15 | 2009 | 5686 | 0.460 |
Why?
|
Sebaceous Glands | 3 | 2009 | 41 | 0.430 |
Why?
|
Lentigo | 3 | 2006 | 37 | 0.430 |
Why?
|
Carcinoma, Basal Cell | 3 | 2005 | 545 | 0.410 |
Why?
|
Skin Pigmentation | 8 | 2004 | 282 | 0.410 |
Why?
|
Laser Coagulation | 4 | 2007 | 326 | 0.390 |
Why?
|
Lasers, Dye | 2 | 2009 | 29 | 0.370 |
Why?
|
Skin Diseases | 6 | 2006 | 1065 | 0.360 |
Why?
|
Environmental Monitoring | 3 | 2008 | 1414 | 0.350 |
Why?
|
Imipramine | 1 | 2009 | 97 | 0.340 |
Why?
|
Facial Dermatoses | 2 | 2008 | 87 | 0.340 |
Why?
|
Phototherapy | 3 | 2006 | 377 | 0.320 |
Why?
|
Coloring Agents | 5 | 2008 | 566 | 0.310 |
Why?
|
Protoporphyrins | 3 | 1997 | 164 | 0.310 |
Why?
|
Hair Follicle | 3 | 1999 | 209 | 0.300 |
Why?
|
Minocycline | 1 | 2008 | 163 | 0.300 |
Why?
|
Lipectomy | 1 | 2008 | 118 | 0.290 |
Why?
|
Body Piercing | 1 | 2006 | 7 | 0.290 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2009 | 434 | 0.290 |
Why?
|
Sweat Gland Neoplasms | 2 | 2005 | 108 | 0.280 |
Why?
|
Skin Diseases, Vascular | 2 | 2005 | 39 | 0.280 |
Why?
|
Wound Healing | 7 | 2006 | 2785 | 0.280 |
Why?
|
Lymphatic Diseases | 1 | 2008 | 324 | 0.280 |
Why?
|
Hidrocystoma | 1 | 2005 | 11 | 0.270 |
Why?
|
Vocal Cords | 3 | 2008 | 528 | 0.270 |
Why?
|
Papilloma | 1 | 2006 | 148 | 0.270 |
Why?
|
Infrared Rays | 3 | 2005 | 249 | 0.260 |
Why?
|
Oximetry | 1 | 2009 | 471 | 0.260 |
Why?
|
Psoriasis | 5 | 2005 | 898 | 0.260 |
Why?
|
Subcutaneous Fat | 1 | 2008 | 391 | 0.260 |
Why?
|
Air Pollutants | 4 | 2008 | 2817 | 0.260 |
Why?
|
Glottis | 1 | 2006 | 217 | 0.250 |
Why?
|
Cheek | 2 | 2004 | 63 | 0.250 |
Why?
|
Varicose Veins | 1 | 2006 | 154 | 0.250 |
Why?
|
Photobiology | 1 | 2004 | 10 | 0.250 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 132 | 0.240 |
Why?
|
Cryosurgery | 1 | 2008 | 453 | 0.230 |
Why?
|
Dust | 1 | 2006 | 482 | 0.230 |
Why?
|
Swine | 8 | 2010 | 5917 | 0.230 |
Why?
|
Lidocaine | 2 | 2006 | 544 | 0.230 |
Why?
|
Hemangioma | 4 | 2009 | 738 | 0.230 |
Why?
|
Beryllium | 1 | 2002 | 13 | 0.220 |
Why?
|
Spectrometry, Fluorescence | 4 | 2000 | 689 | 0.220 |
Why?
|
Laryngeal Neoplasms | 1 | 2006 | 512 | 0.220 |
Why?
|
Monitoring, Intraoperative | 2 | 2009 | 957 | 0.210 |
Why?
|
Arteriovenous Malformations | 1 | 2005 | 396 | 0.200 |
Why?
|
Epidermis | 7 | 2009 | 528 | 0.200 |
Why?
|
Vascular Neoplasms | 1 | 2003 | 175 | 0.200 |
Why?
|
Nevus | 2 | 2001 | 204 | 0.200 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2006 | 454 | 0.200 |
Why?
|
Anesthesia, General | 1 | 2009 | 1171 | 0.200 |
Why?
|
Hemangiosarcoma | 1 | 2003 | 239 | 0.190 |
Why?
|
Microscopy, Fluorescence | 4 | 2004 | 2699 | 0.190 |
Why?
|
Dermabrasion | 1 | 2000 | 13 | 0.180 |
Why?
|
Regional Blood Flow | 1 | 2004 | 1525 | 0.180 |
Why?
|
Erythema | 4 | 2009 | 257 | 0.180 |
Why?
|
Oxides | 1 | 2002 | 405 | 0.180 |
Why?
|
Artifacts | 1 | 2009 | 1904 | 0.180 |
Why?
|
Onychomycosis | 1 | 2000 | 47 | 0.180 |
Why?
|
Dihydroxyacetone | 1 | 1999 | 8 | 0.180 |
Why?
|
Anesthetics, Local | 2 | 2006 | 985 | 0.170 |
Why?
|
Hair | 3 | 1998 | 483 | 0.170 |
Why?
|
Hypertrichosis | 1 | 1999 | 25 | 0.170 |
Why?
|
Hirsutism | 1 | 1999 | 69 | 0.170 |
Why?
|
Pigmentation Disorders | 3 | 2006 | 101 | 0.170 |
Why?
|
Hot Temperature | 5 | 2010 | 1354 | 0.170 |
Why?
|
PUVA Therapy | 1 | 1999 | 98 | 0.170 |
Why?
|
Nevus, Pigmented | 3 | 1999 | 219 | 0.170 |
Why?
|
Lip Diseases | 1 | 1998 | 18 | 0.170 |
Why?
|
Administration, Topical | 4 | 2009 | 690 | 0.160 |
Why?
|
Blood Vessels | 2 | 2004 | 1125 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2005 | 4034 | 0.160 |
Why?
|
Magnetics | 1 | 2002 | 606 | 0.160 |
Why?
|
Aluminum | 1 | 1999 | 152 | 0.160 |
Why?
|
Blood Coagulation | 1 | 2004 | 1127 | 0.150 |
Why?
|
Pennsylvania | 4 | 2008 | 613 | 0.150 |
Why?
|
Dermatitis, Allergic Contact | 1 | 1999 | 104 | 0.150 |
Why?
|
Chorioallantoic Membrane | 2 | 2008 | 47 | 0.150 |
Why?
|
Ink | 2 | 1998 | 44 | 0.150 |
Why?
|
Purpura | 3 | 2009 | 122 | 0.150 |
Why?
|
Condylomata Acuminata | 1 | 1997 | 82 | 0.150 |
Why?
|
Carbon Dioxide | 5 | 2000 | 1150 | 0.150 |
Why?
|
Staining and Labeling | 4 | 2005 | 1100 | 0.150 |
Why?
|
Hamartoma | 1 | 1999 | 238 | 0.150 |
Why?
|
Humans | 82 | 2010 | 744343 | 0.150 |
Why?
|
Melanosis | 2 | 1994 | 78 | 0.140 |
Why?
|
Esthetics | 3 | 2008 | 306 | 0.140 |
Why?
|
Administration, Cutaneous | 4 | 2010 | 711 | 0.140 |
Why?
|
Photography | 3 | 1999 | 520 | 0.130 |
Why?
|
Melanins | 3 | 1995 | 289 | 0.130 |
Why?
|
Organometallic Compounds | 1 | 1999 | 665 | 0.130 |
Why?
|
Adult | 39 | 2009 | 214055 | 0.130 |
Why?
|
Image Enhancement | 2 | 2004 | 2921 | 0.130 |
Why?
|
Education, Medical, Continuing | 2 | 2010 | 840 | 0.120 |
Why?
|
Female | 47 | 2009 | 380194 | 0.120 |
Why?
|
Edema | 3 | 2009 | 789 | 0.120 |
Why?
|
Tolonium Chloride | 2 | 2005 | 23 | 0.120 |
Why?
|
Blister | 2 | 2009 | 86 | 0.120 |
Why?
|
Adipose Tissue | 1 | 2006 | 3279 | 0.120 |
Why?
|
Catheterization | 1 | 2000 | 1470 | 0.120 |
Why?
|
Models, Animal | 3 | 2010 | 2171 | 0.120 |
Why?
|
Animals | 33 | 2010 | 168757 | 0.120 |
Why?
|
Methylene Blue | 2 | 2005 | 155 | 0.120 |
Why?
|
Keratosis | 2 | 2006 | 81 | 0.120 |
Why?
|
Male | 45 | 2010 | 350118 | 0.120 |
Why?
|
Indocyanine Green | 2 | 1992 | 239 | 0.110 |
Why?
|
Iron | 1 | 2002 | 1774 | 0.110 |
Why?
|
Face | 3 | 2005 | 994 | 0.110 |
Why?
|
Cities | 2 | 2006 | 513 | 0.110 |
Why?
|
Nephelometry and Turbidimetry | 1 | 1992 | 91 | 0.110 |
Why?
|
Ultraviolet Therapy | 2 | 2005 | 81 | 0.110 |
Why?
|
Photolysis | 2 | 2007 | 92 | 0.110 |
Why?
|
Microcirculation | 3 | 2007 | 1286 | 0.110 |
Why?
|
Skin Absorption | 2 | 2010 | 94 | 0.100 |
Why?
|
Pilot Projects | 8 | 2009 | 8324 | 0.100 |
Why?
|
Light | 2 | 2003 | 1374 | 0.100 |
Why?
|
Lasers, Gas | 2 | 2010 | 93 | 0.100 |
Why?
|
Particle Size | 4 | 2007 | 1642 | 0.100 |
Why?
|
Middle Aged | 31 | 2009 | 213383 | 0.100 |
Why?
|
Densitometry | 1 | 1991 | 156 | 0.100 |
Why?
|
Hydroxides | 2 | 2001 | 47 | 0.100 |
Why?
|
Potassium Compounds | 2 | 2001 | 40 | 0.100 |
Why?
|
Pigmentation | 2 | 2008 | 148 | 0.100 |
Why?
|
Necrosis | 6 | 2006 | 1643 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 7 | 2009 | 876 | 0.090 |
Why?
|
Contrast Media | 2 | 2002 | 5300 | 0.090 |
Why?
|
Indoles | 1 | 1999 | 1839 | 0.090 |
Why?
|
Melanocytes | 6 | 1999 | 515 | 0.090 |
Why?
|
Erbium | 2 | 2000 | 12 | 0.090 |
Why?
|
Lasers, Semiconductor | 1 | 2009 | 46 | 0.090 |
Why?
|
Neodymium | 3 | 1998 | 21 | 0.080 |
Why?
|
Treatment Outcome | 14 | 2009 | 63114 | 0.080 |
Why?
|
Aluminum Silicates | 3 | 1998 | 26 | 0.080 |
Why?
|
Yttrium | 3 | 1998 | 35 | 0.080 |
Why?
|
Sulfates | 2 | 2007 | 390 | 0.080 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2009 | 93 | 0.080 |
Why?
|
Burns | 3 | 2010 | 1815 | 0.080 |
Why?
|
Rosacea | 1 | 2008 | 49 | 0.080 |
Why?
|
Optics and Photonics | 3 | 1998 | 321 | 0.080 |
Why?
|
Sensitivity and Specificity | 5 | 2010 | 14722 | 0.080 |
Why?
|
Aged | 17 | 2009 | 163280 | 0.080 |
Why?
|
Hypertrophy | 1 | 2009 | 569 | 0.080 |
Why?
|
Time Factors | 12 | 2009 | 40075 | 0.080 |
Why?
|
Endoscopy | 2 | 2008 | 1785 | 0.070 |
Why?
|
Radiometry | 1 | 1992 | 800 | 0.070 |
Why?
|
Melanoma | 2 | 2004 | 5510 | 0.070 |
Why?
|
Skin Temperature | 1 | 2007 | 93 | 0.070 |
Why?
|
Suture Techniques | 1 | 1992 | 798 | 0.070 |
Why?
|
Nitrogen Oxides | 1 | 2006 | 129 | 0.070 |
Why?
|
Mice, Hairless | 3 | 2006 | 41 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2009 | 2327 | 0.070 |
Why?
|
Hoarseness | 1 | 2006 | 65 | 0.070 |
Why?
|
Particulate Matter | 2 | 2008 | 2530 | 0.070 |
Why?
|
United States Environmental Protection Agency | 1 | 2006 | 139 | 0.070 |
Why?
|
Guinea Pigs | 5 | 1992 | 1386 | 0.070 |
Why?
|
Carbon | 2 | 2007 | 687 | 0.070 |
Why?
|
Power Plants | 1 | 2006 | 119 | 0.070 |
Why?
|
Fluorescent Dyes | 3 | 2005 | 1917 | 0.070 |
Why?
|
Biopsy | 8 | 2006 | 6756 | 0.070 |
Why?
|
Electrons | 1 | 2006 | 268 | 0.070 |
Why?
|
Pigments, Biological | 2 | 1998 | 53 | 0.070 |
Why?
|
Apoptosis | 3 | 2010 | 9727 | 0.060 |
Why?
|
History, 20th Century | 2 | 2004 | 2740 | 0.060 |
Why?
|
Arteriosclerosis | 1 | 1990 | 1092 | 0.060 |
Why?
|
Hemoptysis | 1 | 2006 | 155 | 0.060 |
Why?
|
Cicatrix | 3 | 2006 | 764 | 0.060 |
Why?
|
Rose Bengal | 1 | 2005 | 116 | 0.060 |
Why?
|
Time | 1 | 2007 | 542 | 0.060 |
Why?
|
Telangiectasis | 1 | 2005 | 76 | 0.060 |
Why?
|
Meteorological Concepts | 1 | 2004 | 30 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2005 | 39050 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 520 | 0.060 |
Why?
|
Air Movements | 1 | 2004 | 42 | 0.060 |
Why?
|
Joints | 1 | 2006 | 326 | 0.060 |
Why?
|
Prospective Studies | 6 | 2006 | 53288 | 0.060 |
Why?
|
Alopecia | 2 | 1998 | 382 | 0.060 |
Why?
|
Tissue Adhesives | 1 | 2005 | 179 | 0.060 |
Why?
|
Laryngoscopy | 2 | 2007 | 711 | 0.060 |
Why?
|
Ohio | 1 | 2004 | 337 | 0.060 |
Why?
|
Microscopy, Video | 2 | 2007 | 245 | 0.060 |
Why?
|
Online Systems | 1 | 2004 | 184 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2005 | 12959 | 0.060 |
Why?
|
Hand | 1 | 2009 | 884 | 0.060 |
Why?
|
Sutures | 1 | 2005 | 299 | 0.060 |
Why?
|
Knee Joint | 2 | 2005 | 1680 | 0.060 |
Why?
|
Microscopy, Electron | 4 | 1998 | 2645 | 0.060 |
Why?
|
Ozone | 1 | 2006 | 469 | 0.060 |
Why?
|
Menisci, Tibial | 1 | 2005 | 269 | 0.060 |
Why?
|
Music | 1 | 2006 | 263 | 0.060 |
Why?
|
Voice Disorders | 1 | 2006 | 276 | 0.050 |
Why?
|
Pressure | 1 | 2006 | 1203 | 0.050 |
Why?
|
Albinism | 1 | 2002 | 25 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 1 | 2003 | 643 | 0.050 |
Why?
|
Acrospiroma | 1 | 2002 | 13 | 0.050 |
Why?
|
Tinea Pedis | 1 | 2001 | 5 | 0.050 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 898 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1186 | 0.050 |
Why?
|
Fibroblasts | 2 | 2010 | 4161 | 0.050 |
Why?
|
Biopsy, Needle | 3 | 2005 | 1641 | 0.050 |
Why?
|
Japan | 1 | 2006 | 1360 | 0.050 |
Why?
|
Vehicle Emissions | 1 | 2006 | 665 | 0.050 |
Why?
|
Histocytochemistry | 2 | 2001 | 719 | 0.050 |
Why?
|
Forearm | 1 | 2004 | 409 | 0.050 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2006 | 721 | 0.050 |
Why?
|
Dermatologic Agents | 1 | 2005 | 278 | 0.050 |
Why?
|
Models, Economic | 1 | 2005 | 713 | 0.050 |
Why?
|
Ferrosoferric Oxide | 1 | 2002 | 360 | 0.050 |
Why?
|
Cricetinae | 1 | 2004 | 2472 | 0.040 |
Why?
|
Adolescent | 9 | 2009 | 85781 | 0.040 |
Why?
|
Foot Dermatoses | 1 | 2000 | 44 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2006 | 1530 | 0.040 |
Why?
|
DNA Damage | 1 | 2010 | 2432 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2001 | 424 | 0.040 |
Why?
|
Aluminum Oxide | 2 | 1996 | 42 | 0.040 |
Why?
|
Sebaceous Gland Diseases | 1 | 1999 | 5 | 0.040 |
Why?
|
Hyperparathyroidism | 1 | 2000 | 339 | 0.040 |
Why?
|
Patch Tests | 1 | 1999 | 53 | 0.040 |
Why?
|
Rats | 5 | 2006 | 24260 | 0.040 |
Why?
|
Pepsin A | 1 | 1998 | 71 | 0.040 |
Why?
|
Parathyroid Glands | 1 | 2000 | 509 | 0.040 |
Why?
|
Gout | 1 | 2005 | 573 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2008 | 5078 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2003 | 18029 | 0.040 |
Why?
|
Electron Probe Microanalysis | 1 | 1998 | 33 | 0.040 |
Why?
|
Langerhans Cells | 1 | 1999 | 173 | 0.040 |
Why?
|
Dermatitis | 1 | 2000 | 197 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2219 | 0.040 |
Why?
|
Equipment Safety | 1 | 1999 | 264 | 0.040 |
Why?
|
Microsurgery | 1 | 2003 | 796 | 0.040 |
Why?
|
Videotape Recording | 1 | 1999 | 352 | 0.040 |
Why?
|
Nanotechnology | 1 | 2003 | 710 | 0.040 |
Why?
|
Postoperative Period | 1 | 2002 | 1842 | 0.040 |
Why?
|
Joint Capsule | 1 | 1997 | 69 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2000 | 1681 | 0.040 |
Why?
|
Lipids | 1 | 2008 | 3305 | 0.040 |
Why?
|
Keratolytic Agents | 1 | 1997 | 31 | 0.040 |
Why?
|
Cell Size | 1 | 1999 | 643 | 0.040 |
Why?
|
Mice | 6 | 2007 | 81183 | 0.040 |
Why?
|
Mice, Nude | 1 | 2003 | 3689 | 0.040 |
Why?
|
Eczema | 1 | 1999 | 231 | 0.040 |
Why?
|
Ploidies | 1 | 1997 | 281 | 0.040 |
Why?
|
Equipment Design | 1 | 2005 | 3582 | 0.040 |
Why?
|
Liver Diseases | 1 | 2005 | 1253 | 0.030 |
Why?
|
Cafe-au-Lait Spots | 1 | 1995 | 18 | 0.030 |
Why?
|
Physical Phenomena | 1 | 1996 | 46 | 0.030 |
Why?
|
Rupture | 2 | 2008 | 433 | 0.030 |
Why?
|
Keloid | 1 | 1996 | 50 | 0.030 |
Why?
|
Hyperplasia | 4 | 2000 | 1185 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3396 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4568 | 0.030 |
Why?
|
Physics | 1 | 1996 | 87 | 0.030 |
Why?
|
Chick Embryo | 2 | 2008 | 982 | 0.030 |
Why?
|
Child | 3 | 2009 | 77709 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1678 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 694 | 0.030 |
Why?
|
Infant | 2 | 2009 | 35136 | 0.030 |
Why?
|
Risk Assessment | 2 | 2008 | 23338 | 0.030 |
Why?
|
Leg | 1 | 2000 | 1116 | 0.030 |
Why?
|
Rabbits | 4 | 2000 | 4894 | 0.030 |
Why?
|
Vasodilation | 1 | 1999 | 944 | 0.030 |
Why?
|
Cadaver | 3 | 2007 | 1337 | 0.030 |
Why?
|
Child, Preschool | 2 | 2009 | 41006 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2000 | 752 | 0.030 |
Why?
|
Hypopigmentation | 1 | 1994 | 41 | 0.030 |
Why?
|
Vitiligo | 1 | 1995 | 89 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9687 | 0.030 |
Why?
|
Mathematics | 1 | 1995 | 728 | 0.030 |
Why?
|
Single-Blind Method | 1 | 1998 | 1590 | 0.030 |
Why?
|
Keratinocytes | 2 | 1997 | 798 | 0.030 |
Why?
|
Ethiopia | 1 | 1996 | 495 | 0.030 |
Why?
|
Models, Biological | 3 | 2008 | 9583 | 0.030 |
Why?
|
Arteries | 2 | 2008 | 1119 | 0.030 |
Why?
|
Tretinoin | 1 | 1997 | 517 | 0.030 |
Why?
|
Vitamin A | 1 | 1997 | 615 | 0.030 |
Why?
|
Dihematoporphyrin Ether | 1 | 1992 | 31 | 0.030 |
Why?
|
Collagen | 2 | 1998 | 2689 | 0.030 |
Why?
|
Treatment Failure | 2 | 1999 | 2618 | 0.030 |
Why?
|
Pain Measurement | 1 | 2002 | 3420 | 0.030 |
Why?
|
Sensation | 1 | 1994 | 336 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15540 | 0.030 |
Why?
|
Age Factors | 1 | 2009 | 18370 | 0.030 |
Why?
|
Cosmetics | 1 | 1993 | 97 | 0.030 |
Why?
|
Color | 1 | 1993 | 307 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4933 | 0.030 |
Why?
|
Models, Structural | 1 | 1992 | 361 | 0.030 |
Why?
|
Dogs | 1 | 1996 | 3912 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2001 | 57776 | 0.030 |
Why?
|
Ferric Compounds | 1 | 1993 | 374 | 0.020 |
Why?
|
Rats, Wistar | 2 | 2006 | 1901 | 0.020 |
Why?
|
Health Care Costs | 1 | 2005 | 3209 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2000 | 1161 | 0.020 |
Why?
|
Public Health | 1 | 2004 | 2603 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 279 | 0.020 |
Why?
|
Radiation Injuries, Experimental | 1 | 1991 | 91 | 0.020 |
Why?
|
Gels | 1 | 1992 | 427 | 0.020 |
Why?
|
Tensile Strength | 1 | 1992 | 335 | 0.020 |
Why?
|
Cytoplasm | 1 | 1995 | 1539 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2006 | 15295 | 0.020 |
Why?
|
Micronucleus Tests | 1 | 2010 | 23 | 0.020 |
Why?
|
Kidney | 1 | 2006 | 7186 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1999 | 2969 | 0.020 |
Why?
|
Endometrium | 1 | 1992 | 424 | 0.020 |
Why?
|
Cohort Studies | 2 | 2009 | 40561 | 0.020 |
Why?
|
Electronics | 1 | 1991 | 322 | 0.020 |
Why?
|
Prevalence | 1 | 2006 | 15226 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 1991 | 498 | 0.020 |
Why?
|
Radiation Injuries | 1 | 1997 | 1180 | 0.020 |
Why?
|
Radiation Dosage | 1 | 1998 | 1928 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2004 | 19905 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7474 | 0.020 |
Why?
|
Heat-Shock Response | 1 | 2010 | 165 | 0.020 |
Why?
|
Elements | 1 | 2008 | 20 | 0.020 |
Why?
|
United States | 2 | 2006 | 69872 | 0.020 |
Why?
|
Spectrophotometry, Atomic | 1 | 2008 | 81 | 0.020 |
Why?
|
Dendritic Cells | 1 | 1999 | 2725 | 0.020 |
Why?
|
Immunoblotting | 1 | 1991 | 1682 | 0.020 |
Why?
|
Culture Media | 1 | 2010 | 908 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8301 | 0.020 |
Why?
|
Sheep | 1 | 1990 | 1437 | 0.020 |
Why?
|
Cell Movement | 1 | 1999 | 5217 | 0.020 |
Why?
|
Urinary Calculi | 1 | 1987 | 91 | 0.020 |
Why?
|
Young Adult | 2 | 2009 | 56430 | 0.020 |
Why?
|
Nitrates | 1 | 2007 | 265 | 0.020 |
Why?
|
Lithotripsy | 1 | 1987 | 143 | 0.020 |
Why?
|
Collagen Type III | 1 | 2006 | 90 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2003 | 10180 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15076 | 0.020 |
Why?
|
Photochemistry | 1 | 2005 | 238 | 0.020 |
Why?
|
Cholelithiasis | 1 | 1987 | 414 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1991 | 1681 | 0.020 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2006 | 285 | 0.020 |
Why?
|
Aorta | 2 | 1990 | 2061 | 0.020 |
Why?
|
Chondrocalcinosis | 1 | 2005 | 79 | 0.020 |
Why?
|
Titanium | 1 | 2007 | 494 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2006 | 404 | 0.010 |
Why?
|
Energy Transfer | 1 | 2003 | 109 | 0.010 |
Why?
|
Swine, Miniature | 1 | 2005 | 961 | 0.010 |
Why?
|
Phosphates | 1 | 2007 | 786 | 0.010 |
Why?
|
Nanotubes | 1 | 2003 | 77 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 2007 | 662 | 0.010 |
Why?
|
DNA | 1 | 1997 | 7301 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 2006 | 435 | 0.010 |
Why?
|
Cell Communication | 1 | 2010 | 1621 | 0.010 |
Why?
|
Reference Values | 1 | 1990 | 4982 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1616 | 0.010 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2006 | 687 | 0.010 |
Why?
|
Coated Materials, Biocompatible | 1 | 2003 | 319 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2006 | 764 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2009 | 77449 | 0.010 |
Why?
|
Microspheres | 1 | 2003 | 777 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2006 | 11366 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 1998 | 21827 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2007 | 1198 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
Sunlight | 1 | 2001 | 325 | 0.010 |
Why?
|
Parathyroid Neoplasms | 1 | 2000 | 245 | 0.010 |
Why?
|
Actins | 1 | 2006 | 2121 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.010 |
Why?
|
Incidence | 1 | 1996 | 20947 | 0.010 |
Why?
|
Cattle | 2 | 1997 | 3922 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1997 | 237 | 0.010 |
Why?
|
Iontophoresis | 1 | 1997 | 74 | 0.010 |
Why?
|
Regeneration | 1 | 2006 | 1485 | 0.010 |
Why?
|
Software | 1 | 1991 | 4443 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
Liposomes | 1 | 1998 | 759 | 0.010 |
Why?
|
Pain | 1 | 2009 | 4986 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2000 | 1801 | 0.010 |
Why?
|
Drug Carriers | 1 | 1998 | 693 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 1866 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8642 | 0.010 |
Why?
|
Rats, Nude | 1 | 1992 | 105 | 0.010 |
Why?
|
Microscopy | 1 | 1997 | 903 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2005 | 5391 | 0.010 |
Why?
|
Algorithms | 1 | 1992 | 13881 | 0.010 |
Why?
|
Cell Count | 1 | 1995 | 1856 | 0.010 |
Why?
|
Shoulder Joint | 1 | 1997 | 695 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 1992 | 290 | 0.010 |
Why?
|
Adenoma | 1 | 2000 | 2174 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1992 | 1420 | 0.010 |
Why?
|
Risk Factors | 1 | 1996 | 72290 | 0.010 |
Why?
|
Cell Cycle | 1 | 1997 | 2967 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 7279 | 0.000 |
Why?
|
Calcium | 1 | 2000 | 5756 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2003 | 19229 | 0.000 |
Why?
|
Ultraviolet Rays | 1 | 1992 | 1060 | 0.000 |
Why?
|
Forecasting | 1 | 1995 | 2951 | 0.000 |
Why?
|
Heart Injuries | 1 | 1988 | 210 | 0.000 |
Why?
|
Recurrence | 1 | 1995 | 8340 | 0.000 |
Why?
|
Models, Anatomic | 1 | 1987 | 691 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1992 | 10943 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1997 | 11483 | 0.000 |
Why?
|